34 research outputs found

    P2Y6 receptor potentiates pro-inflammatory responses in macrophages and exhibits differential roles in atherosclerotic lesion development.

    No full text
    BACKGROUND: P2Y(6), a purinergic receptor for UDP, is enriched in atherosclerotic lesions and is implicated in pro-inflammatory responses of key vascular cell types and macrophages. Evidence for its involvement in atherogenesis, however, has been lacking. Here we use cell-based studies and three murine models of atherogenesis to evaluate the impact of P2Y(6) deficiency on atherosclerosis. METHODOLOGY/PRINCIPAL FINDINGS: Cell-based studies in 1321N1 astrocytoma cells, which lack functional P2Y(6) receptors, showed that exogenous expression of P2Y(6) induces a robust, receptor- and agonist-dependent secretion of inflammatory mediators IL-8, IL-6, MCP-1 and GRO1. P2Y(6)-mediated inflammatory responses were also observed, albeit to a lesser extent, in macrophages endogenously expressing P2Y(6) and in acute peritonitis models of inflammation. To evaluate the role of P2Y(6) in atherosclerotic lesion development, we used P2Y(6)-deficient mice in three mouse models of atherosclerosis. A 43% reduction in aortic arch plaque was observed in high fat-fed LDLR knockout mice lacking P2Y(6) receptors in bone marrow-derived cells. In contrast, no effect on lesion development was observed in fat-fed whole body P2Y(6)xLDLR double knockout mice. Interestingly, in a model of enhanced vascular inflammation using angiotensin II, P2Y(6) deficiency enhanced formation of aneurysms and exhibited a trend towards increased atherosclerosis in the aorta of LDLR knockout mice. CONCLUSIONS: P2Y(6) receptor augments pro-inflammatory responses in macrophages and exhibits a pro-atherogenic role in hematopoietic cells. However, the overall impact of whole body P2Y(6) deficiency on atherosclerosis appears to be modest and could reflect additional roles of P2Y(6) in vascular disease pathophysiologies, such as aneurysm formation

    Genetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred Strains.

    No full text
    Common forms of atherosclerosis involve multiple genetic and environmental factors. While human genome-wide association studies have identified numerous loci contributing to coronary artery disease and its risk factors, these studies are unable to control environmental factors or examine detailed molecular traits in relevant tissues. We now report a study of natural variations contributing to atherosclerosis and related traits in over 100 inbred strains of mice from the Hybrid Mouse Diversity Panel (HMDP). The mice were made hyperlipidemic by transgenic expression of human apolipoprotein E-Leiden (APOE-Leiden) and human cholesteryl ester transfer protein (CETP). The mice were examined for lesion size and morphology as well as plasma lipid, insulin and glucose levels, and blood cell profiles. A subset of mice was studied for plasma levels of metabolites and cytokines. We also measured global transcript levels in aorta and liver. Finally, the uptake of acetylated LDL by macrophages from HMDP mice was quantitatively examined. Loci contributing to the traits were mapped using association analysis, and relationships among traits were examined using correlation and statistical modeling. A number of conclusions emerged. First, relationships among atherosclerosis and the risk factors in mice resemble those found in humans. Second, a number of trait-loci were identified, including some overlapping with previous human and mouse studies. Third, gene expression data enabled enrichment analysis of pathways contributing to atherosclerosis and prioritization of candidate genes at associated loci in both mice and humans. Fourth, the data provided a number of mechanistic inferences; for example, we detected no association between macrophage uptake of acetylated LDL and atherosclerosis. Fifth, broad sense heritability for atherosclerosis was much larger than narrow sense heritability, indicating an important role for gene-by-gene interactions. Sixth, stepwise linear regression showed that the combined variations in plasma metabolites, including LDL/VLDL-cholesterol, trimethylamine N-oxide (TMAO), arginine, glucose and insulin, account for approximately 30 to 40% of the variation in atherosclerotic lesion area. Overall, our data provide a rich resource for studies of complex interactions underlying atherosclerosis

    Abdominal Aortic Aneurysms.

    No full text
    <p><b>A</b>) Incidence of aneurysm development in the abdominal aorta. <b>B</b>) Representative images of abdominal aortic aneurysms for P2Y<sub>6</sub> KO mice and P2Y<sub>6</sub> wild-type mice. Aneurysm-positive and -negative aortas are given for P2Y<sub>6</sub> KO wild type mice. Aneurysms are demarcated by the white boxes. <b>C</b>) Trichrome-stained histological sections of aneurysms taken from the supra-renal section of the abdominal aorta. Sections were cut from the center of the aneurysm mass. The single asterisk denotes the highly inflamed and remodeled adventitial mass. The double asterisk denotes a region of apparent hemorrhage. Neo-intimal plaque is shown by the arrows. The image at the far right shows an abdominal aorta cross-section taken from P2Y<sub>6</sub> wild type mice. The magnification scale for each image is shown.</p

    Atherosclerosis development with P2Y<sub>6</sub>-deficient bone marrow reconstitution.

    No full text
    <p><b>A</b>) Quantification of en face lesion area with oil red O staining in the whole aorta from the ascending aorta to the iliac bifurcation and <b>B</b>) aortic arch. <b>C</b>) Representative images of aortic arch atherosclerosis. Group sizes: n = 9 P2Y<sub>6</sub> WT transplanted mice; n = 14 P2Y<sub>6</sub> KO transplanted mice. Significance vs. control: *p<0.05. <i>Not significant, n.s.</i></p

    Accelerated Atherosclerosis development with Angiotensin II infusion.

    No full text
    <p>Atherosclerosis development measured in the aorta with oil red O. <b>A</b>) Quantification of en face lesion area in the thoracic aorta (ascending aorta to the diaphragm). Regional atherosclerosis in <b>B</b>) aortic arch and <b>C</b>) descending thoracic aorta segments. Group sizes: n = 9 P2Y<sub>6</sub> WT mice; n = 14 P2Y<sub>6</sub> KO mice. The fold change in P2Y<sub>6</sub> lesion area is given relative to P2Y<sub>6</sub> wild type levels. <i>Not significant, n.s.</i></p

    P2Y<sub>6</sub> knockout mice exhibit reduced responsiveness to inflammatory challenge.

    No full text
    <p>Generation and evaluation of P2Y<sub>6</sub> KO mice. <b>A</b>) Targeting strategy used to replace the 3<sup>rd</sup> exon of the P2Y<sub>6</sub> gene containing the entire open reading frame with a pKOS-17 vector containing β-galactosidase (LacZ) reporter and neomycin resistance (Neo) cassette. The second and third exon of the P2Y<sub>6</sub> gene are depicted as grey boxes with indicated translational start and stop codons. Location of Southern Blot probes is shown in green and blue, and PCR genotyping primers are shown in red. <b>B</b>) MPMs from P2Y<sub>6</sub> knockout mice (KO) and wild type littermates (WT) were incubated with increasing concentrations of 3P-UDP to generate calcium concentration response curves. Calculated EC<sub>50</sub> value for WT MPMs is shown. <b>C</b>) P2Y<sub>6</sub> KO males and WT male littermates (n =  4–5 per group) were subjected to intra-peritoneal challenge with vehicle, MSU or combination of MSU and 3P-UDP (1mg/mouse each) as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0111385#s2" target="_blank">Materials and Methods</a>. Blood was collected 1 hr after injection and cytokines in plasma measured by multiplex ELISA. Cytokines that displayed differential responses in KO mice are shown. Baseline (unchallenged mice) and vehicle treated mice are also depicted for MIP-1α. Significance KO vs WT: **p<0.01 *p<0.05. <i>Not significant, n.s.</i></p

    P2Y<sub>6</sub> expression mediates release of calcium and pro-inflammatory cytokines in 1321N1 cells.

    No full text
    <p>Evaluation of calcium release and cytokine secretion to cell culture media in 1321N1 astrocytoma cells stably expressing human P2Y<sub>6</sub> receptor. <b>A</b>) Isolated 1321N1 clones expressing varying levels of P2Y<sub>6</sub> mRNA and mock transfected cells (Parental) were incubated with increasing concentrations of UDP and 3P-UDP. Calcium mobilization was measured to generate concentration response curves with examples shown for 3G10 clone and parental cell line. For each clone, achieved maximal calcium response is expressed as percentage relative to 3G10 clone (set as 100%) together with calculated EC<sub>50</sub> values (ND  =  not determined) and relative P2Y<sub>6</sub> mRNA levels (relative to parental cells, which had very low but detectable P2Y<sub>6</sub> mRNA). <b>B</b>) 1321N1 clones were incubated for 20 hr with increasing concentrations of 3P-UDP and cytokines in cell culture medium quantified using multiplex ELISA as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0111385#s2" target="_blank">Materials and Methods</a>. Each cytokine was normalized to cellular protein content. The data are presented as mean +/− SD of replicate wells.</p
    corecore